NDAC’s busy schedule
This article was originally published in The Tan Sheet
Executive Summary
A two-day joint meeting of the Nonprescription and Dermatologic & Ophthalmic Drugs Advisory Committees is scheduled for March 24-25. The two committees discussed labeling issues for OTC athlete's foot drugs during a meeting in May (1"The Tan Sheet," May 10, 2004, p. 10). NDAC also is scheduled to meet with the Endocrinologic & Metabolic Drugs Advisory Committee Jan. 13-14...